3 Health Services Stocks Pushing The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 16,024 as of Friday, Nov. 22, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,437 issues advancing vs. 1,443 declining with 136 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is up 0.2%. Top gainers within the industry include Boston Scientific ( BSX), up 0.8%, Cigna ( CI), up 0.7% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.5%. On the negative front, top decliners within the industry include Covance ( CVD), down 1.2%, DaVita HealthCare Partners ( DVA), down 1.1%, Grifols ( GRFS), down 0.8% and St Jude Medical ( STJ), down 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. WuXi PharmaTech (Cayman ( WX) is one of the companies pushing the Health Services industry higher today. As of noon trading, WuXi PharmaTech (Cayman is up $0.72 (2.2%) to $33.00 on average volume. Thus far, 294,282 shares of WuXi PharmaTech (Cayman exchanged hands as compared to its average daily volume of 506,500 shares. The stock has ranged in price between $32.30-$33.31 after having opened the day at $32.30 as compared to the previous trading day's close of $32.28.

Wuxi PharmaTech (Cayman) Inc., through its subsidiaries, operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company in China and the United States. It operates in two segments, Laboratory Services and Manufacturing Services. WuXi PharmaTech (Cayman has a market cap of $2.3 billion and is part of the health care sector. The company has a P/E ratio of 21.6, above the S&P 500 P/E ratio of 17.7. Shares are up 105.0% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate WuXi PharmaTech (Cayman a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates WuXi PharmaTech (Cayman as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full WuXi PharmaTech (Cayman Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Cooper Companies ( COO) is up $1.55 (1.2%) to $133.77 on average volume. Thus far, 127,228 shares of Cooper Companies exchanged hands as compared to its average daily volume of 285,600 shares. The stock has ranged in price between $131.87-$134.47 after having opened the day at $132.49 as compared to the previous trading day's close of $132.22.

The Cooper Companies, Inc. operates as a medical device company worldwide. Cooper Companies has a market cap of $6.3 billion and is part of the health care sector. The company has a P/E ratio of 20.4, above the S&P 500 P/E ratio of 17.7. Shares are up 43.0% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Cooper Companies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cooper Companies Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Humana ( HUM) is up $1.35 (1.4%) to $101.07 on average volume. Thus far, 497,750 shares of Humana exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $99.76-$101.26 after having opened the day at $99.80 as compared to the previous trading day's close of $99.72.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $15.6 billion and is part of the health care sector. The company has a P/E ratio of 11.0, below the S&P 500 P/E ratio of 17.7. Shares are up 45.3% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists